Literature DB >> 3528309

Cutaneous acute graft-versus-host disease to minor histocompatibility antigens in a murine model: histologic analysis and correlation to clinical disease.

J Ferrara, F J Guillen, B Sleckman, S J Burakoff, G F Murphy.   

Abstract

Graft-versus-host disease (GVHD) can occur in bone marrow-transplant recipients even when donor and host are identically matched at the major histocompatibility complex. GVHD in this context presumably arises because of differences in minor histocompatibility antigens. Murine GVHD to minor histocompatibility antigens has been studied in an effort to determine whether skin is a target of the immune response in this model system. T cell-depleted marrow cells (10(7)) from B10.BR (H-2k) mice were supplemented with varying numbers of nylon wool-enriched splenic B10.BR T cells and transplanted intravenously into irradiated (1100 R) CBA (H-2k) mice. Sequential biopsies of ear skin were obtained at weekly intervals over a 7-week period. Histopathologic evaluation revealed basal cell layer vacuolization, exocytosis, and satellitosis of mononuclear cells in the epidermis. Dyskeratosis was observed only in animals receiving T cells, and proved to be the most reliable histologic parameter of disease with the number of dyskeratotic cells per linear millimeter of epidermis correlating both with severity of clinical disease and with the number of transplanted T cells. Ultrastructural examination revealed exocytosis of mononuclear cells into the epidermis where they were frequently apposed to degenerating and necrotic keratinocytes. These data indicate that the skin is an informative target organ for study of experimental GVHD to minor histocompatibility antigens.

Entities:  

Mesh:

Year:  1986        PMID: 3528309     DOI: 10.1111/1523-1747.ep12285612

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  22 in total

1.  Absence of beta7 integrin results in less graft-versus-host disease because of decreased homing of alloreactive T cells to intestine.

Authors:  Elisha Waldman; Sydney X Lu; Vanessa M Hubbard; Adam A Kochman; Jeffrey M Eng; Theis H Terwey; Stephanie J Muriglan; Theo D Kim; Glenn Heller; George F Murphy; Chen Liu; Onder Alpdogan; Marcel R M van den Brink
Journal:  Blood       Date:  2005-11-15       Impact factor: 22.113

Review 2.  Bone marrow transplantation: the genetic and cellular basis of resistance to engraftment and acute graft-versus-host disease.

Authors:  J Ferrara; P Mauch; G Murphy; S J Burakoff
Journal:  Surv Immunol Res       Date:  1985

3.  Absence of inducible costimulator on alloreactive T cells reduces graft versus host disease and induces Th2 deviation.

Authors:  Vanessa M Hubbard; Jeffrey M Eng; Teresa Ramirez-Montagut; Kartono H Tjoe; Stephanie J Muriglan; Adam A Kochman; Theis H Terwey; Lucy M Willis; Rafaella Schiro; Glen Heller; George F Murphy; Chen Liu; Onder Alpdogan; Marcel R M van den Brink
Journal:  Blood       Date:  2005-06-14       Impact factor: 22.113

4.  Cytolytic T cells induce ceramide-rich platforms in target cell membranes to initiate graft-versus-host disease.

Authors:  Jimmy A Rotolo; Branka Stancevic; Sydney X Lu; Jianjun Zhang; David Suh; Christopher G King; Lucy W Kappel; George F Murphy; Chen Liu; Zvi Fuks; Marcel R van den Brink; Richard Kolesnick
Journal:  Blood       Date:  2009-08-07       Impact factor: 22.113

5.  A preclinical acute GVHD mouse model based on chemotherapy conditioning and MHC-matched transplantation.

Authors:  K Riesner; M Kalupa; Y Shi; S Elezkurtaj; O Penack
Journal:  Bone Marrow Transplant       Date:  2015-11-23       Impact factor: 5.483

6.  Importance of minor histocompatibility antigen expression by nonhematopoietic tissues in a CD4+ T cell-mediated graft-versus-host disease model.

Authors:  Stephen C Jones; George F Murphy; Thea M Friedman; Robert Korngold
Journal:  J Clin Invest       Date:  2003-12       Impact factor: 14.808

7.  Beta2 integrins separate graft-versus-host disease and graft-versus-leukemia effects.

Authors:  Yaming Liang; Chen Liu; Julie Y Djeu; Bin Zhong; Thorsten Peters; Karin Scharffetter-Kochanek; Claudio Anasetti; Xue-Zhong Yu
Journal:  Blood       Date:  2007-10-10       Impact factor: 22.113

Review 8.  Target cells in graft-versus-host disease: implications for cancer therapy.

Authors:  George F Murphy
Journal:  Clin Rev Allergy Immunol       Date:  2007-08-14       Impact factor: 8.667

9.  Transplantation of T cell-mediated, lymphoreticular disease from the scurfy (sf) mouse.

Authors:  V L Godfrey; B T Rouse; J E Wilkinson
Journal:  Am J Pathol       Date:  1994-08       Impact factor: 4.307

10.  Organ-derived dendritic cells have differential effects on alloreactive T cells.

Authors:  Theo D Kim; Theis H Terwey; Johannes L Zakrzewski; David Suh; Adam A Kochman; Megan E Chen; Chris G King; Chiara Borsotti; Jeremy Grubin; Odette M Smith; Glenn Heller; Chen Liu; George F Murphy; Onder Alpdogan; Marcel R M van den Brink
Journal:  Blood       Date:  2008-01-04       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.